Fundamentals-based quality & risk · not a recommendation
Raw blend 49 capped to 40 by a red flag.
Raw blend 49 → capped to 40
CMRSL scores 40/100 (Caution) on the Orion Score — moderate business quality (53), poor growth (27) and moderate balance-sheet safety (63). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
—/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹25.39 | ₹1.04 | 4.4% | ₹3.55 |
| Q3 2026 | ₹22.29 | ₹0.55 | 5.3% | ₹1.88 |
| Q2 2026 | ₹21.13 | ₹0.83 | 5.0% | ₹2.84 |
| Q1 2026 | ₹22.01 | ₹1.06 | 5.3% | ₹3.63 |
| Q4 2025 | ₹18.35 | ₹0.42 | 2.9% | ₹1.44 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹90.82 | ₹3.48 | ₹5.13 | 5.0% |
| FY 2025 | ₹75.03 | ₹2.32 | ₹3.73 | 3.6% |
| FY 2024 | ₹87.33 | ₹3.59 | ₹6.02 | 6.8% |
| FY 2023 | ₹63.13 | ₹2.12 | ₹4.4 | 6.8% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹43.7 | ₹41.06 | ₹34.31 | ₹28.17 |
| Equity | ₹17.24 | ₹15.53 | ₹12.54 | ₹3.77 |
| Total Debt | ₹6.11 | ₹8.6 | ₹6.8 | ₹9.71 |
| Cash | ₹4.24 | ₹4.18 | ₹7.6 | ₹5.4 |
| Net Debt | ₹1.87 | ₹4.43 | — | ₹4.32 |
| Working Capital | ₹12.36 | ₹12.38 | ₹8.64 | ₹1.17 |
Q3 FY2026
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q3 FY2026 | 42.42% | 0.93% | — | 56.65% |
| Q2 FY2026 | 42.42% | 0.93% ↓ | — | 56.65% ↑ |
| Q1 FY2026 | 42.42% | 2.05% ↓ | — | 55.53% ↑ |
| Q4 FY2025 | 42.42% | 3.77% | — | 53.81% |
| Q3 FY2025 | 42.42% | 3.77% | — | 53.81% |
| Q2 FY2025 | 42.42% | 3.77% | — | 53.81% |
| Q1 FY2025 | 42.42% | 3.77% | — | 53.81% |
| Q4 FY2024 | 42.42% | 3.77% | — | 53.81% |
No recent corporate actions
Ask: "Is CMRSL stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.